Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details)

v3.22.2.2
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) - shares
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Antidilutive securities, shares 883,234 777,629
Common Stock Options [Member]    
Antidilutive securities, shares 177,815 27,815
Common Stock Warrants [Member]    
Antidilutive securities, shares 242,639 188,892
Conversion of Convertible Notes and Accured Interest [Member]    
Antidilutive securities, shares 79,727  
Conversion of Series A Stock Inclusive of Cumulative Dividends [Member]    
Antidilutive securities, shares 111,563  
Conversion of Series B Preferred Stock Inclusive of Dividends [Member]    
Antidilutive securities, shares 271,490  
Conversion of Debentures [Member]    
Antidilutive securities, shares   5,469
Conversion of Series A Stock [Member]    
Antidilutive securities, shares   107,172
Conversion of Series B Preferred Stock [Member]    
Antidilutive securities, shares   235,781
Conversion of Series E-1 Preferred Stock [Member].    
Antidilutive securities, shares   212,500